What is Medifast's D&A?

Medifast (MED) reported D&A of $3.48M in Q1 2026.

How has Medifast's D&A changed year-over-year?

Medifast's D&A increased by 6.2% year-over-year, from $3.28M to $3.48M.

What is the long-term trend for Medifast's D&A?

Over 4 years (2021 to 2025), Medifast's D&A has grown at a 20.2% compound annual growth rate (CAGR), from $6.81M to $14.24M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Medifast MED D&A

D&A at other companies

HerbalifeHLF

$29.4M-4.2%

Segments

By segment

See full

Optavia Segment$2.6M+13.0%

Other financials

Income statement

See full

Revenue$76.0M-34.3%

Gross profit$51.8M-38.6%

Operating income-$3.3M-161%

Net income-$2.1M-175%

EPS (diluted)-$0.19-171%

Balance sheet

See full

Cash & equivalents$71.5M-22.0%

Total debt$16.1M+10.2%

Total equity$197.7M-6.3%

Total assets$252.0M-10.0%

Cash flow

See full

Operating cash flow$260.0K-92.4%

CapEx$1.1M-28.0%

Free cash flow-$836.0K-144%

Valuation

See full

Market cap$121.87M-17.4%

Enterprise value$66.44M+12.8%

P/S0.4×0.0×

Profitability

See full

Gross margin70.1%-3.8pp

Operating margin-4.7%-7.0pp

Net margin-5.8%-8.1pp

FCF margin5%-9.3pp

Returns & leverage

See full

Return on equity-9.8%-20.1pp

Debt / equity0.1×0.0×

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medifast's D&A?: Medifast (MED) reported D&A of $3.48M in Q1 2026.
How has Medifast's D&A changed year-over-year?: Medifast's D&A increased by 6.2% year-over-year, from $3.28M to $3.48M.
What is the long-term trend for Medifast's D&A?: Over 4 years (2021 to 2025), Medifast's D&A has grown at a 20.2% compound annual growth rate (CAGR), from $6.81M to $14.24M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.